TRIPLE-NEGATIVE OR HER2-POSITIVE STATUS PREDICTS HIGHER RATES OF LOCOREGIONAL RECURRENCE IN NODE-POSITIVE BREAST CANCER PATIENTS AFTER MASTECTOMY
Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy